Måndag 4 November | 02:29:21 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

Tid*
2024-11-14 07:00 Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-08-14 - Extra Bolagsstämma 2024
2024-05-29 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 - Årsstämma
2024-05-15 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-03-02 - Bokslutskommuniké 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-26 - Kvartalsrapport 2021-Q2
2021-06-17 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 - Årsstämma
2021-05-27 - Kvartalsrapport 2021-Q1
2021-03-02 - Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2021-06-25 23:56:22
Circa Group AS: Resolution to increase share capital
OSLO, NORWAY - 25 June 2021. The board of directors of Circa Group AS (the
"Company") has today, 25 June 2021 resolved to issue 851,160 new shares
following the exercise of warrants by Moata Pty Ltd on 25 June 2021, a close
associate of the Company's CEO, Anthony Duncan.
The new shares will increase the Company's share capital to NOK 121,713,109
divided into 121,713,109 shares, each with a nominal value of NOK 1.
Following the exercise of warrants, Anthony Duncan and close associates have
increased their shareholding from 5,908,840 shares to 6,760,000 shares.
About Circa
Established in 2006, Circa Group converts waste, non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM, an alternative to traditional polar aprotic solvents, which is produced
in one step from platform biomolecule Levoglucosenone. By creating renewable
chemicals from cellulose, Circa is extracting value from non-food, waste biomass
and addressing a gap in the market by providing bio-based alternatives
contributing to a more circular economy. In March 2021, Circa Group successfully
listed on the Euronext Growth Market in Oslo, stock symbol CIRCA.
www.circagroup.com.au
Media Contact
Kathryn Sheridan
Sustainability Consult
ks@sustainabilityconsult.com
www.sustainabilityconsult.com